世界のフラグメントベースの創薬市場：市場規模・現状・予測

• 英文タイトル：Global Fragment-based Drug Discovery Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7221
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、94ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

当資料は、フラグメントベースの創薬のグローバル市場について調査・分析したレポートで、種類別（NMR分光法、DSFアッセイ、蛍光偏光（FP）、等温滴定熱量測定（ITC）、X線結晶学）、用途別（バイオ医薬品会社、CRO、学術研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・フラグメントベースの創薬の世界市場規模
・主要企業別市場シェア
・フラグメントベースの創薬の世界市場規模：種類別（NMR分光法、DSFアッセイ、蛍光偏光（FP）、等温滴定熱量測定（ITC）、X線結晶学）
・フラグメントベースの創薬の世界市場規模：用途別（バイオ医薬品会社、CRO、学術研究機関）
・フラグメントベースの創薬のアメリカ市場規模（種類別、用途別）
・フラグメントベースの創薬のヨーロッパ市場規模（種類別、用途別）
・フラグメントベースの創薬の中国市場規模（種類別、用途別）
・フラグメントベースの創薬の日本市場規模（種類別、用途別）
・フラグメントベースの創薬の東南アジア市場規模（種類別、用途別）
・フラグメントベースの創薬のインド市場規模（種類別、用途別）
・フラグメントベースの創薬の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・フラグメントベースの創薬の世界市場予測（2019年-2025年）
・フラグメントベースの創薬の地域別市場予測（2019年-2025年）
...

In 2018, the global Fragment-based Drug Discovery market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Fragment-based Drug Discovery status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Fragment-based Drug Discovery development in United States, Europe and China.

The key players covered in this study
Astex Pharmaceuticals
Alveus Pharmaceuticals Pvt. Ltd
Beactica AB
Charles River Laboratories International, Inc
Crown Bioscience, Inc
Emerald BioStructures, Inc
Evotec AG
Kinetic Discovery Limited
Proteros Fragments GmbH
Sprint Bioscience
Structure Based Design, Inc
Sygnature Discovery

Market segment by Type, the product can be split into
NMR Spectroscopy
DSF Assay
Fluorescence Polarization (FP)
Isothermal Titration Calorimetry (ITC)
X-ray Crystallography

Market segment by Application, split into
Biopharmaceutical Companies
CROs
Academic and Research Institutions

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Fragment-based Drug Discovery status, future forecast, growth opportunity, key market and key players.
To present the Fragment-based Drug Discovery development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Fragment-based Drug Discovery are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Fragment-based Drug Discovery Market Size Growth Rate by Type (2014-2025)
1.4.2 NMR Spectroscopy
1.4.3 DSF Assay
1.4.4 Fluorescence Polarization (FP)
1.4.5 Isothermal Titration Calorimetry (ITC)
1.4.6 X-ray Crystallography
1.5 Market by Application
1.5.1 Global Fragment-based Drug Discovery Market Share by Application (2014-2025)
1.5.2 Biopharmaceutical Companies
1.5.3 CROs
1.5.4 Academic and Research Institutions
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Fragment-based Drug Discovery Market Size
2.2 Fragment-based Drug Discovery Growth Trends by Regions
2.2.1 Fragment-based Drug Discovery Market Size by Regions (2014-2025)
2.2.2 Fragment-based Drug Discovery Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Fragment-based Drug Discovery Market Size by Manufacturers
3.1.1 Global Fragment-based Drug Discovery Revenue by Manufacturers (2014-2019)
3.1.2 Global Fragment-based Drug Discovery Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Fragment-based Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.2 Fragment-based Drug Discovery Key Players Head office and Area Served
3.3 Key Players Fragment-based Drug Discovery Product/Solution/Service
3.4 Date of Enter into Fragment-based Drug Discovery Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Fragment-based Drug Discovery Market Size by Type (2014-2019)
4.2 Global Fragment-based Drug Discovery Market Size by Application (2014-2019)

5 United States
5.1 United States Fragment-based Drug Discovery Market Size (2014-2019)
5.2 Fragment-based Drug Discovery Key Players in United States
5.3 United States Fragment-based Drug Discovery Market Size by Type
5.4 United States Fragment-based Drug Discovery Market Size by Application

6 Europe
6.1 Europe Fragment-based Drug Discovery Market Size (2014-2019)
6.2 Fragment-based Drug Discovery Key Players in Europe
6.3 Europe Fragment-based Drug Discovery Market Size by Type
6.4 Europe Fragment-based Drug Discovery Market Size by Application

7 China
7.1 China Fragment-based Drug Discovery Market Size (2014-2019)
7.2 Fragment-based Drug Discovery Key Players in China
7.3 China Fragment-based Drug Discovery Market Size by Type
7.4 China Fragment-based Drug Discovery Market Size by Application

8 Japan
8.1 Japan Fragment-based Drug Discovery Market Size (2014-2019)
8.2 Fragment-based Drug Discovery Key Players in Japan
8.3 Japan Fragment-based Drug Discovery Market Size by Type
8.4 Japan Fragment-based Drug Discovery Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Fragment-based Drug Discovery Market Size (2014-2019)
9.2 Fragment-based Drug Discovery Key Players in Southeast Asia
9.3 Southeast Asia Fragment-based Drug Discovery Market Size by Type
9.4 Southeast Asia Fragment-based Drug Discovery Market Size by Application

10 India
10.1 India Fragment-based Drug Discovery Market Size (2014-2019)
10.2 Fragment-based Drug Discovery Key Players in India
10.3 India Fragment-based Drug Discovery Market Size by Type
10.4 India Fragment-based Drug Discovery Market Size by Application

11 Central & South America
11.1 Central & South America Fragment-based Drug Discovery Market Size (2014-2019)
11.2 Fragment-based Drug Discovery Key Players in Central & South America
11.3 Central & South America Fragment-based Drug Discovery Market Size by Type
11.4 Central & South America Fragment-based Drug Discovery Market Size by Application

12 International Players Profiles
12.1 Astex Pharmaceuticals
12.1.1 Astex Pharmaceuticals Company Details
12.1.2 Company Description and Business Overview
12.1.3 Fragment-based Drug Discovery Introduction
12.1.4 Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2014-2019)
12.1.5 Astex Pharmaceuticals Recent Development
12.2 Alveus Pharmaceuticals Pvt. Ltd
12.2.1 Alveus Pharmaceuticals Pvt. Ltd Company Details
12.2.2 Company Description and Business Overview
12.2.3 Fragment-based Drug Discovery Introduction
12.2.4 Alveus Pharmaceuticals Pvt. Ltd Revenue in Fragment-based Drug Discovery Business (2014-2019)
12.2.5 Alveus Pharmaceuticals Pvt. Ltd Recent Development
12.3 Beactica AB
12.3.1 Beactica AB Company Details
12.3.2 Company Description and Business Overview
12.3.3 Fragment-based Drug Discovery Introduction
12.3.4 Beactica AB Revenue in Fragment-based Drug Discovery Business (2014-2019)
12.3.5 Beactica AB Recent Development
12.4 Charles River Laboratories International, Inc
12.4.1 Charles River Laboratories International, Inc Company Details
12.4.2 Company Description and Business Overview
12.4.3 Fragment-based Drug Discovery Introduction
12.4.4 Charles River Laboratories International, Inc Revenue in Fragment-based Drug Discovery Business (2014-2019)
12.4.5 Charles River Laboratories International, Inc Recent Development
12.5 Crown Bioscience, Inc
12.5.1 Crown Bioscience, Inc Company Details
12.5.2 Company Description and Business Overview
12.5.3 Fragment-based Drug Discovery Introduction
12.5.4 Crown Bioscience, Inc Revenue in Fragment-based Drug Discovery Business (2014-2019)
12.5.5 Crown Bioscience, Inc Recent Development
12.6 Emerald BioStructures, Inc
12.6.1 Emerald BioStructures, Inc Company Details
12.6.2 Company Description and Business Overview
12.6.3 Fragment-based Drug Discovery Introduction
12.6.4 Emerald BioStructures, Inc Revenue in Fragment-based Drug Discovery Business (2014-2019)
12.6.5 Emerald BioStructures, Inc Recent Development
12.7 Evotec AG
12.7.1 Evotec AG Company Details
12.7.2 Company Description and Business Overview
12.7.3 Fragment-based Drug Discovery Introduction
12.7.4 Evotec AG Revenue in Fragment-based Drug Discovery Business (2014-2019)
12.7.5 Evotec AG Recent Development
12.8 Kinetic Discovery Limited
12.8.1 Kinetic Discovery Limited Company Details
12.8.2 Company Description and Business Overview
12.8.3 Fragment-based Drug Discovery Introduction
12.8.4 Kinetic Discovery Limited Revenue in Fragment-based Drug Discovery Business (2014-2019)
12.8.5 Kinetic Discovery Limited Recent Development
12.9 Proteros Fragments GmbH
12.9.1 Proteros Fragments GmbH Company Details
12.9.2 Company Description and Business Overview
12.9.3 Fragment-based Drug Discovery Introduction
12.9.4 Proteros Fragments GmbH Revenue in Fragment-based Drug Discovery Business (2014-2019)
12.9.5 Proteros Fragments GmbH Recent Development
12.10 Sprint Bioscience
12.10.1 Sprint Bioscience Company Details
12.10.2 Company Description and Business Overview
12.10.3 Fragment-based Drug Discovery Introduction
12.10.4 Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2014-2019)
12.10.5 Sprint Bioscience Recent Development
12.11 Structure Based Design, Inc
12.12 Sygnature Discovery

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Fragment-based Drug Discovery Key Market Segments
Table Key Players Fragment-based Drug Discovery Covered
Table Global Fragment-based Drug Discovery Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Fragment-based Drug Discovery Market Size Market Share by Type 2014-2025
Figure NMR Spectroscopy Figures
Table Key Players of NMR Spectroscopy
Figure DSF Assay Figures
Table Key Players of DSF Assay
Figure Fluorescence Polarization (FP) Figures
Table Key Players of Fluorescence Polarization (FP)
Figure Isothermal Titration Calorimetry (ITC) Figures
Table Key Players of Isothermal Titration Calorimetry (ITC)
Figure X-ray Crystallography Figures
Table Key Players of X-ray Crystallography
Table Global Fragment-based Drug Discovery Market Size Growth by Application 2014-2025 (Million US$)
Figure Biopharmaceutical Companies Case Studies
Figure CROs Case Studies
Figure Academic and Research Institutions Case Studies
Figure Fragment-based Drug Discovery Report Years Considered
Table Global Fragment-based Drug Discovery Market Size 2014-2025 (Million US$)
Figure Global Fragment-based Drug Discovery Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Fragment-based Drug Discovery Market Size by Regions 2014-2025 (Million US$)
Table Global Fragment-based Drug Discovery Market Size by Regions 2014-2019 (Million US$)
Table Global Fragment-based Drug Discovery Market Share by Regions 2014-2019
Figure Global Fragment-based Drug Discovery Market Share by Regions 2014-2019
Figure Global Fragment-based Drug Discovery Market Share by Regions 2019
Table Market Top Trends
Table Global Fragment-based Drug Discovery Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Fragment-based Drug Discovery Market Share by Manufacturers (2014-2019)
Figure Global Fragment-based Drug Discovery Market Share by Manufacturers in 2018
Table Global Fragment-based Drug Discovery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Fragment-based Drug Discovery Product/Solution/Service
Table Date of Enter into Fragment-based Drug Discovery Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Fragment-based Drug Discovery Market Size by Type (2014-2019) (Million US$)
Table Global Fragment-based Drug Discovery Market Size Share by Type (2014-2019)
Figure Global Fragment-based Drug Discovery Market Size Market Share by Type (2014-2019)
Table Global Fragment-based Drug Discovery Market Size by Application (2014-2019) (Million US$)
Table Global Fragment-based Drug Discovery Market Size Share by Application (2014-2019)
Figure Global Fragment-based Drug Discovery Market Size Market Share by Application (2014-2019)
Figure Global Fragment-based Drug Discovery Revenue Market Share by Application in 2018
Figure United States Fragment-based Drug Discovery Market Size 2014-2019 (Million US$)
Table United States Key Players Fragment-based Drug Discovery Revenue (2018-2019) (Million US$)
Table United States Key Players Fragment-based Drug Discovery Market Share (2018-2019)
Table United States Fragment-based Drug Discovery Market Size by Type (2014-2019) (Million US$)
Table United States Fragment-based Drug Discovery Market Share by Type (2014-2019)
Table United States Fragment-based Drug Discovery Market Size by Application (2014-2019) (Million US$)
Table United States Fragment-based Drug Discovery Market Share by Application (2014-2019)
Figure Europe Fragment-based Drug Discovery Market Size 2014-2019 (Million US$)
Table Europe Key Players Fragment-based Drug Discovery Revenue (2018-2019) (Million US$)
Table Europe Key Players Fragment-based Drug Discovery Market Share (2018-2019)
Table Europe Fragment-based Drug Discovery Market Size by Type (2014-2019) (Million US$)
Table Europe Fragment-based Drug Discovery Market Share by Type (2014-2019)
Table Europe Fragment-based Drug Discovery Market Size by Application (2014-2019) (Million US$)
Table Europe Fragment-based Drug Discovery Market Share by Application (2014-2019)
Figure China Fragment-based Drug Discovery Market Size 2014-2019 (Million US$)
Table China Key Players Fragment-based Drug Discovery Revenue (2018-2019) (Million US$)
Table China Key Players Fragment-based Drug Discovery Market Share (2018-2019)
Table China Fragment-based Drug Discovery Market Size by Type (2014-20189) (Million US$)
Table China Fragment-based Drug Discovery Market Share by Type (2014-2019)
Table China Fragment-based Drug Discovery Market Size by Application (2014-2019) (Million US$)
Table China Fragment-based Drug Discovery Market Share by Application (2014-2019)
Figure Japan Fragment-based Drug Discovery Market Size 2014-2019 (Million US$)
Table Japan Key Players Fragment-based Drug Discovery Revenue (2018-2019) (Million US$)
Table Japan Key Players Fragment-based Drug Discovery Market Share (2018-2019)
Table Japan Fragment-based Drug Discovery Market Size by Type (2014-2019) (Million US$)
Table Japan Fragment-based Drug Discovery Market Share by Type (2014-2019)
Table Japan Fragment-based Drug Discovery Market Size by Application (2014-2019) (Million US$)
Table Japan Fragment-based Drug Discovery Market Share by Application (2014-2019)
Figure Southeast Asia Fragment-based Drug Discovery Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Fragment-based Drug Discovery Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Fragment-based Drug Discovery Market Share (2018-2019)
Table Southeast Asia Fragment-based Drug Discovery Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Fragment-based Drug Discovery Market Share by Type (2014-2019)
Table Southeast Asia Fragment-based Drug Discovery Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Fragment-based Drug Discovery Market Share by Application (2014-2019)
Figure India Fragment-based Drug Discovery Market Size 2014-2019 (Million US$)
Table India Key Players Fragment-based Drug Discovery Revenue (2018-2019) (Million US$)
Table India Key Players Fragment-based Drug Discovery Market Share (2018-2019)
Table India Fragment-based Drug Discovery Market Size by Type (2014-2019) (Million US$)
Table India Fragment-based Drug Discovery Market Share by Type (2014-2019)
Table India Fragment-based Drug Discovery Market Size by Application (2014-2019) (Million US$)
Table India Fragment-based Drug Discovery Market Share by Application (2014-2019)
Figure Central & South America Fragment-based Drug Discovery Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Fragment-based Drug Discovery Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Fragment-based Drug Discovery Market Share (2018-2019)
Table Central & South America Fragment-based Drug Discovery Market Size by Type (2014-2019) (Million US$)
Table Central & South America Fragment-based Drug Discovery Market Share by Type (2014-2019)
Table Central & South America Fragment-based Drug Discovery Market Size by Application (2014-2019) (Million US$)
Table Central & South America Fragment-based Drug Discovery Market Share by Application (2014-2019)
Table Astex Pharmaceuticals Company Details
Table Astex Pharmaceuticals Revenue in Fragment-based Drug Discovery Business (2014-2019) (Million US$)
Figure Astex Pharmaceuticals Revenue Growth Rate in Fragment-based Drug Discovery Business (2014-2019)
Table Astex Pharmaceuticals Recent Development
Table Alveus Pharmaceuticals Pvt. Ltd Company Details
Table Alveus Pharmaceuticals Pvt. Ltd Revenue in Fragment-based Drug Discovery Business (2014-2019)(Million US$)
Figure Alveus Pharmaceuticals Pvt. Ltd Revenue Growth Rate in Fragment-based Drug Discovery Business (2014-2019)
Table Alveus Pharmaceuticals Pvt. Ltd Recent Development
Table Beactica AB Company Details
Table Beactica AB Revenue in Fragment-based Drug Discovery Business (2014-2019)(Million US$)
Figure Beactica AB Revenue Growth Rate in Fragment-based Drug Discovery Business (2014-2019)
Table Beactica AB Recent Development
Table Charles River Laboratories International, Inc Company Details
Table Charles River Laboratories International, Inc Revenue in Fragment-based Drug Discovery Business (2014-2019)(Million US$)
Figure Charles River Laboratories International, Inc Revenue Growth Rate in Fragment-based Drug Discovery Business (2014-2019)
Table Charles River Laboratories International, Inc Recent Development
Table Crown Bioscience, Inc Company Details
Table Crown Bioscience, Inc Revenue in Fragment-based Drug Discovery Business (2014-2019)(Million US$)
Figure Crown Bioscience, Inc Revenue Growth Rate in Fragment-based Drug Discovery Business (2014-2019)
Table Crown Bioscience, Inc Recent Development
Table Emerald BioStructures, Inc Company Details
Table Emerald BioStructures, Inc Revenue in Fragment-based Drug Discovery Business (2014-2019)(Million US$)
Figure Emerald BioStructures, Inc Revenue Growth Rate in Fragment-based Drug Discovery Business (2014-2019)
Table Emerald BioStructures, Inc Recent Development
Table Evotec AG Company Details
Table Evotec AG Revenue in Fragment-based Drug Discovery Business (2014-2019)(Million US$)
Figure Evotec AG Revenue Growth Rate in Fragment-based Drug Discovery Business (2014-2019)
Table Evotec AG Recent Development
Table Kinetic Discovery Limited Company Details
Table Kinetic Discovery Limited Revenue in Fragment-based Drug Discovery Business (2014-2019)(Million US$)
Figure Kinetic Discovery Limited Revenue Growth Rate in Fragment-based Drug Discovery Business (2014-2019)
Table Kinetic Discovery Limited Recent Development
Table Proteros Fragments GmbH Company Details
Table Proteros Fragments GmbH Revenue in Fragment-based Drug Discovery Business (2014-2019)(Million US$)
Figure Proteros Fragments GmbH Revenue Growth Rate in Fragment-based Drug Discovery Business (2014-2019)
Table Proteros Fragments GmbH Recent Development
Table Sprint Bioscience Company Details
Table Sprint Bioscience Revenue in Fragment-based Drug Discovery Business (2014-2019)(Million US$)
Figure Sprint Bioscience Revenue Growth Rate in Fragment-based Drug Discovery Business (2014-2019)
Table Sprint Bioscience Recent Development
Table Structure Based Design, Inc Company Details
Table Sygnature Discovery Company Details
Table Global Fragment-based Drug Discovery Market Size by Regions (Million US$) 2019-2025
Figure Global Fragment-based Drug Discovery Market Size Share by Regions (2019-2025)
Figure Global Fragment-based Drug Discovery Market Size Share by Regions in 2025
Figure United States Fragment-based Drug Discovery Market Size Forecast (2019-2025)(Million USD)
Figure Europe Fragment-based Drug Discovery Market Size Forecast (2019-2025)(Million USD)
Figure China Fragment-based Drug Discovery Market Size Forecast (2019-2025)(Million USD)
Figure Japan Fragment-based Drug Discovery Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Fragment-based Drug Discovery Market Size Forecast (2019-2025)(Million USD)
Figure India Fragment-based Drug Discovery Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Fragment-based Drug Discovery Market Size Forecast (2019-2025)(Million USD)
Table Global Fragment-based Drug Discovery Market Size by Product (2019-2025) (Million US$)
Figure Global Fragment-based Drug Discovery Market Size by Product (2019-2025)
Figure Global Fragment-based Drug Discovery Market Size by Product in 2025
Table Global Fragment-based Drug Discovery Market Size by Application (2019-2025) (Million US$)
Figure Global Fragment-based Drug Discovery Market Size by Application (2019-2025)
Figure Global Fragment-based Drug Discovery Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介

世界の外注創薬市場：市場規模・現状・予測

Global Outsourced Drug Discovery Market Size, Status and Forecast 2019-2025
QYR9N7744 2019年6月14日 95Pages
当資料は、外注創薬のグローバル市場について調査・分析したレポートで、種類別（化学サービス、生物学的サービス、リード最適化、リード識別とスクリーニング）、用途別（製薬会社、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれ...

世界の小分子創薬市場：市場規模・現状・予測

Global Small-Molecule Drug Discovery Market Size, Status and Forecast 2019-2025
QYR9N8061 2019年6月14日 93Pages
当資料は、小分子創薬のグローバル市場について調査・分析したレポートで、種類別（丸薬、錠剤、その他）、用途別（腫瘍学、心血管、皮膚科、中枢神経系、呼吸器系、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界のスニチニブ薬市場：市場規模・現状・予測

Global Sunitinib Drug Market Size, Status and Forecast 2019-2025
QYR9N8092 2019年6月14日 92Pages
当資料は、スニチニブ薬のグローバル市場について調査・分析したレポートで、種類別（12.5 mgのカプセル、25 mgカプセル、37.5 mgカプセル、50 mgカプセル）、用途別（腎臓がん、GIST、pNET）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市...

世界のデシタビン薬市場：市場規模・現状・予測

Global Decitabine Drug Market Size, Status and Forecast 2019-2025
QYR9N7070 2019年6月14日 95Pages
当資料は、デシタビン薬のグローバル市場について調査・分析したレポートで、種類別（ダコゲン、ジェネリック）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・デ...

世界の鎮痛剤デリバリー市場：市場規模・現状・予測

Global Pain Drug Delivery Market Size, Status and Forecast 2019-2025
QYR9N7754 2019年6月14日 94Pages
当資料は、鎮痛剤デリバリーのグローバル市場について調査・分析したレポートで、種類別（経皮ドラッグデリバリーシステム、髄腔内ドラッグデリバリーシステム、その他）、用途別（腫瘍学、神経学的障害、肺疾患、ホルモン障害、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市...

世界のシクロベンザプリン薬市場：市場規模・現状・予測

Global Cyclobenzaprine Drug Market Size, Status and Forecast 2019-2025
QYR9N7055 2019年6月14日 94Pages
当資料は、シクロベンザプリン薬のグローバル市場について調査・分析したレポートで、種類別（タブレット、カプセル）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

...

世界のレボセチリジン薬市場：市場規模・現状・予測

Global Levocetirizine Drug Market Size, Status and Forecast 2019-2025
QYR9N7449 2019年6月14日 97Pages
当資料は、レボセチリジン薬のグローバル市場について調査・分析したレポートで、種類別（錠剤、経口液）、用途別（65歳以上、12〜64歳、6〜11歳、2〜5歳）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。
...

世界のDNAベースのスキンケア市場：市場規模・現状・予測

Global DNA-Based Skin Care Market Size, Status and Forecast 2019-2025
QYR9N7127 2019年6月14日 90Pages
当資料は、DNAベースのスキンケアのグローバル市場について調査・分析したレポートで、種類別（セラム、クリーム、酸化防止剤、その他）、用途別（ウェルネスクリニック、ホームユーザー、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報など...

世界のチゲサイクリン薬市場：市場規模・現状・予測

Global Tigecycline Drug Market Size, Status and Forecast 2019-2025
QYR9N8124 2019年6月14日 93Pages
当資料は、チゲサイクリン薬のグローバル市場について調査・分析したレポートで、種類別（TYGACIL、ジェネリック）、用途別（病院、ドラッグストア）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

世界の経鼻剤デリバリー市場：市場規模・現状・予測

Global Nasal Drug Delivery Market Size, Status and Forecast 2019-2025
QYR9N7628 2019年6月14日 98Pages
当資料は、経鼻剤デリバリーのグローバル市場について調査・分析したレポートで、種類別（ドロップ、スプレー、パウダー、ゲルと軟膏）、用途別（アレルギー性および非アレルギー性鼻炎、鼻詰まり、予防接種）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業...

世界の外注創薬市場：市場規模・現状・予測 In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which new candidate medications are discovered. Historically, drugs were discovered through identifying the active ingredient from traditional remedies or by serendipitousdiscovery.In 2018, the global Outsour…
世界の小分子創薬市場：市場規模・現状・予測 In 2018, the global Small-Molecule Drug Discovery market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Small-Molecule Drug Discovery status, future forecast, growth opportunity, key market…
世界の受容体アッセイ市場：市場規模・現状・予測 The cell receptor assay is used to evaluate the first step in the molecular action of the drug biologic, its interaction with a specific cellular receptor.The major drivers for the growth of the the global receptor assays market are the continuous increase in R&D expenditures and increasing research…
世界のスニチニブ薬市場：市場規模・現状・予測 Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
世界のデシタビン薬市場：市場規模・現状・予測 Decitabine (trade name Dacogen), or 5-aza-2'-deoxycytidine, acts as an Nucleic Acid Synthesis Inhibitor. It is a drug for the treatment of myelodysplastic syndromes, a class of conditions where certain blood cells are dysfunctional, and for acute myeloid leukemia (AML).In 2018, the global Decitabine…